Concepedia

Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial

Simon Nadel, Brahm Goldstein, Mark D. Williams, Heidi J. Dalton, Mark Peters, William L. Macias, Shamel Abd‐Allah, Howard Levy, Robinette Angle, Dazhe Wang,

The Lancet · 2007 · 501 citations · 13 references

DOI

Concepts

References

13

Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care

Derek C. Angus, Walter T. Linde‐Zwirble, Jeffrey Lidicker et al. · Critical Care Medicine · 2001 · 8.6K citations

, , +16

Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis

Gordon R. Bernard, Jean‐Louis Vincent, Pierre‐François Laterre et al. · New England Journal of Medicine · 2001 · 6.1K citations · Full text

, , +13

PRISM III

Murray M. Pollack, Kantilal M. Patel, Urs E. Ruttimann · Critical Care Medicine · 1996 · 1.7K citations

, , +14

Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death

Edward Abraham, Pierre‐François Laterre, Rekha Garg et al. · New England Journal of Medicine · 2005 · 890 citations · Full text

, , +17

The Epidemiology of Severe Sepsis in Children in the United States

R. Scott Watson, Joseph A. Carcillo, Walter T. Linde‐Zwirble et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 877 citations

, , +12